The Future of BCMA-Targeting in Myeloma

Noopur Raje, MD, director of the multiple myeloma program at Massachusetts General Hospital, looks into the future of BCMA-targeting CAR T-cell therapies such as bb21217 and how this class of agents will fit in the myeloma treatment landscape.